According to Insmed's latest financial reports the company's current earnings are S$0.34 Billion. In 2023 the company made an earning of -S$0.91 Billion a decrease over its 2022 earnings that were of -S$0.63 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$1.04 Billion | 14.55% |
2023 | -S$0.91 Billion | 45.77% |
2022 | -S$0.63 Billion | 15.83% |
2021 | -S$0.54 Billion | 50.19% |
2020 | -S$0.36 Billion | 16.4% |
2019 | -S$0.31 Billion | -23.9% |
2018 | -S$0.41 Billion | 59.35% |
2017 | -S$0.26 Billion | 8.52% |
2016 | -S$0.24 Billion | 47.25% |
2015 | -S$0.16 Billion | 34.53% |
2014 | -S$0.12 Billion | 58.83% |
2013 | -S$74.06 Million | 35.14% |
2012 | -S$54.81 Million | -31.92% |
2011 | -S$80.5 Million | 854.92% |
2010 | -S$8.43 Million | -105.22% |
2009 | S$0.16 B | -905.06% |
2008 | -S$20.05 Million | -27.31% |
2007 | -S$27.59 Million | -62.41% |
2006 | -S$73.38 Million | 98.19% |
2005 | -S$37.03 Million | 0.03% |
2004 | -S$37.01 Million | 159.07% |
2003 | -S$14.29 Million | -69.31% |
2002 | -S$46.55 Million | |
2000 | -S$41.97 Million |